文献速递肿瘤 PET/CT

实体瘤18F-FLT定量摄取测量的可重复性:个体患者数据多中心荟萃分析

Repeatability of quantitative 18F-FLT uptake measurements in solid tumors: an individual patient data multi-center meta-analysis.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2018-01-23

该研究通过系统检索PubMed、EMBASE.com和Cochrane图书馆(建库至2016年10月),纳入四个18F-FLT可重复性队列共30例患者52个病灶,采用统一肿瘤分割方法和可重复性指标重新分析个体患者数据。结果显示所有18F-FLT摄取指标重测相关性良好(R²≥0.93;ICC≥0.96),SUVpeak可重复性最佳(RC:23.1%),增殖体积(RC:36.0%)和TLU(RC:36.4%)可重复性差于SUV。结论认为多中心研究中18F-FLT SUV指标差异≥25%可能代表肿瘤摄取的真实变化。

要点

  • 所有18F-FLT摄取指标重测相关性良好(R²≥0.93;ICC≥0.96)。
  • SUVpeak可重复性最佳(RC:23.1%),不同SUV指标间RC无显著差异。
  • 增殖体积(RC:36.0%)和TLU(RC:36.4%)可重复性差于SUV。

核心结论

  • 多中心研究中,18F-FLT SUV指标差异≥25%可能代表肿瘤摄取的真实变化。
  • 当未应用病灶选择标准时,包含体积估计的FLT指标需要更大的差异。

研究设计与样本

  • 系统检索PubMed、EMBASE.com和Cochrane图书馆(建库至2016年10月),获得五个18F-FLT可重复性队列。
  • 最终纳入四个队列共30例患者52个病灶(乳腺癌10个、头颈部鳞状细胞癌9个、非小细胞肺癌33个)。
  • 采用50%等轮廓线适配局部本底在测试和重测扫描上勾画18F-FLT高摄取病灶,计算SUVmax、SUVmean、SUVpeak、增殖体积和总病灶摄取(TLU)。
  • 采用可重复性系数(RC=1.96×重测差值的标准差)、线性回归分析和组内相关系数(ICC)评估可重复性,并评估不同病灶选择标准的影响。

主要发现

  • 所有18F-FLT摄取指标重测数据间相关性良好(R²≥0.93;ICC≥0.96)。
  • SUVpeak可重复性最佳(RC:23.1%),不同SUV指标间RC无显著差异。
  • 增殖体积(RC:36.0%)和TLU(RC:36.4%)的可重复性差于SUV。
  • 基于SUVmax≥4.0的病灶选择方法改善了体积指标的可重复性(RC:26-28%),但不影响SUV指标的可重复性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: 3'-deoxy-3'-[18F]fluorothymidine (18F-FLT) positron emission tomography (PET) provides a non-invasive method to assess cellular proliferation and response to antitumor therapy. Quantitative 18F-FLT uptake metrics are being used for evaluation of proliferative response in investigational setting, however multi-center repeatability needs to be established. The aim of this study was to determine the repeatability of 18F-FLT tumor uptake metrics by re-analyzing individual patient data from previously published reports using the same tumor segmentation method and repeatability metrics across cohorts. METHODS: A systematic search in PubMed, EMBASE.com and the Cochrane Library from inception-October 2016 yielded five 18F-FLT repeatability cohorts in solid tumors. 18F-FLT avid lesions were delineated using a 50% isocontour adapted for local background on test and retest scans. SUVmax, SUVmean, SUVpeak, proliferative volume and total lesion uptake (TLU) were calculated. Repeatability was assessed using the repeatability coefficient (RC = 1.96 × SD of test-retest differences), linear regression analysis, and the intra-class correlation coefficient (ICC). The impact of different lesion selection criteria was also evaluated. RESULTS: Images from four cohorts containing 30 patients with 52 lesions were obtained and analyzed (ten in breast cancer, nine in head and neck squamous cell carcinoma, and 33 in non-small cell lung cancer patients). A good correlation was found between test-retest data for all 18F-FLT uptake metrics (R2 ≥ 0.93; ICC ≥ 0.96). Best repeatability was found for SUVpeak (RC: 23.1%), without significant differences in RC between different SUV metrics. Repeatability of proliferative volume (RC: 36.0%) and TLU (RC: 36.4%) was worse than SUV. Lesion selection methods based on SUVmax ≥ 4.0 improved the repeatability of volumetric metrics (RC: 26-28%), but did not affect the repeatability of SUV metrics. CONCLUSIONS: In multi-center studies, differences ≥ 25% in 18F-FLT SUV metrics likely represent a true change in tumor uptake. Larger differences are required for FLT metrics comprising volume estimates when no lesion selection criteria are applied.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Kramer GM, Liu Y, de Langen AJ, et al. Repeatability of quantitative 18F-FLT uptake measurements in solid tumors: an individual patient data multi-center meta-analysis. Eur J Nucl Med Mol Imaging. 2018. PMID: 29362858. doi:10.1007/s00259-017-3923-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。